Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors

GlobeNewswire

WILLIAMSVILLE, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next generation plant biotechnology, today announced the appointment of Michael Koganov, Sc.D., Ph.D., to its Board of Directors...

Mentions: NYSE 22nd Century Group, Inc. Board